Sat.Jul 13, 2024 - Fri.Jul 19, 2024

article thumbnail

Vaccination slashes risk of long Covid, says large study tracing cases through Delta and Omicron variants

STAT

Vaccination lowers the chance of developing long Covid, according to a large new study that also found that the risk of serious complications has diminished but not disappeared as new coronavirus variants emerged. The study, published Wednesday in the New England Journal of Medicine , compared the health records of more than 440,000 Veterans Affairs patients who were infected with Covid-19 with records of more than 4 million uninfected people.

Vaccines 364
article thumbnail

Has pharma emerged from the ‘age of uncertainty’?

PharmaVoice

An industry reeling from a precarious market is showing signs of stabilizing as the future becomes a little less cloudy, an Evaluate report suggests.

265
265
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Artiva prices $167M IPO, riding optimism for autoimmune cell therapy

BioPharma Dive

The offering comes days after the publication of a paper showing what analysts said was early proof that “off-the-shelf” cell therapies can treat inflammatory diseases.

129
129
article thumbnail

Endo Recalls Clonazepam Because of Mislabeling

PharmaTech

The company has issued a voluntary recall of one lot of Clonazepam Orally Disintegrating Tablets, USP (C-IV), because of incorrect strength published on product carton.

118
118
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

At an Iowa county fair, a tradition carries on despite bird flu anxiety in the dairy barn

STAT

DECORAH, Iowa — It was livestock check-in day at the Winneshiek County Fair, and the dairy barn was consumed with a kind of pre-prom anxiety. A cow named Daiquiri was lumbering back from the milking parlor, adjusting to a new schedule that would have her “mammary system” bulging for showtime. Kennedy was getting a fresh shave, tufts of udder-fuzz drifting to the floor, revealing her resplendent venation.

363
363
article thumbnail

Gilead eyes ‘ending the HIV epidemic’ via incremental progress

PharmaVoice

With a long elusive HIV cure ever on the horizon, Gilead’s latest long-acting PrEP study shows that every step counts.

246
246

More Trending

article thumbnail

South-east London pharmacies launch inhaler recycling pilot

The Pharmacist

Community pharmacies in south-east London have launched what is believed to be England’s only nationally-funded inhaler recycling pilot. NHS England (NHSE) has funded the scheme, which aims to reduce greenhouse gases from metered dose inhalers. Patients will be encouraged to return their used or expired inhalers to one of 20 participating community pharmacies.

article thumbnail

Microsoft global outage forces health systems to cancel appointments, delay procedures

STAT

On Thursday, a widespread outage to Microsoft systems took down computers in health systems around the globe, leading many to cancel non-urgent medical appointments and surgeries as they encouraged patients to make plans for disrupted travel and delays in care. “A major worldwide software outage has affected many of our systems at Mass General Brigham,” the hospital system shared in a statement on Friday.

article thumbnail

Kyverna follows oncology’s CAR-T cell playbook for an ultra-rare autoimmune disorder

PharmaVoice

The pharma company is tackling the “stiff person syndrome” that afflicts Celine Dion in a phase 2 trial for its lead CAR-T candidate.

174
174
article thumbnail

Sionna revives AbbVie’s cystic fibrosis drugs, eyeing a shot at Vertex

BioPharma Dive

The well-funded startup says drugs AbbVie abandoned last year could form a combination regimen with “superior efficacy” to Vertex’s market-leading medicines.

111
111
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

PBMs will face House committee grilling next week

pharmaphorum

The House Committee on Oversight and Accountability will quiz leaders of pharmacy benefit managers (PBMs) at a hearing next week, amid scrutiny of the sector's role in rising healthcare costs in the US.The hearing – scheduled for 23rd July – is part of an ongoing investigation by the committee into PBMs' alleged anticompetitive practices launched last year and spearheaded by chairman James Comer (R-Ky).

117
117
article thumbnail

Opinion: Functional neurological disorder is not an appropriate diagnosis for people with long Covid

STAT

Long Covid — the name adopted for cases of prolonged symptoms after an acute bout of Covid-19 — is an umbrella diagnosis covering a broad range of clinical presentations and abnormal biological processes. Researchers haven’t yet identified a single or defining cause for some of the most debilitating symptoms associated with long Covid, which parallel those routinely seen in other post-acute infection syndromes.

364
364
article thumbnail

Is a better CAR-T cell therapy option on the horizon?

PharmaVoice

In vivo CAR-T cell technology has the potential to solve some major issues in the field and could enter the clinic this year.

174
174
article thumbnail

Obesity pill from Roche shows promising weight loss in small study

BioPharma Dive

Treatment led to "clinically meaningful" weight loss over four weeks, but longer studies will be needed to compare it to Wegovy and Zepbound.

120
120
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Merck launches GMP-compliant cell culture media line in China

Pharmaceutical Business Review

The new line, representing an investment of nearly €6.6m ($7.1m), is located at the Life Science Center in Nantong. This development is aimed at meeting the increasing local demand for high-quality custom CCM, critical in the production of biopharmaceuticals, vaccines, and new therapeutics. The commercialisation of the Nantong facility’s production line will allow Chinese customers to access established range of custom CCM products and services of Merck.

Vaccines 107
article thumbnail

Opinion: Why aren’t philanthropists stepping up to support nursing education?

STAT

Michael Bloomberg’s donation of $1 billion to Johns Hopkins University to support medical education goes beyond similar gifts to other medical schools. The Bloomberg gift provides support to students in Hopkins’ schools of nursing and public health, not just in its medical school. As health professionals and educators, we are thrilled to see philanthropists supporting the future of medical training in the U.S.

article thumbnail

Clinical development rates are falling - but it’s not all bad news

pharmaphorum

While clinical development rates are falling, there is still hope in the Phase I bio sector. Learn more about the potential opportunities and positives in this challenging trend.

111
111
article thumbnail

GSK’s application for Blenrep for MM treatment accepted for EMA review

Pharmafile

GSK has announced that the European Medicines Agency (EMA) has accepted the marketing authorisation application (MAA) for Blenrep (belantamab mafodotin) in combination with bortezombin plus dexamethasone (BorDex) or pomalidomide plus dexamethasone (PomDex) as a treatment for relapsed or refractory (R/R) multiple myeloma (MM). The post GSK’s application for Blenrep for MM treatment accepted for EMA review appeared first on Pharmafile.

105
105
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Advances in neurological research highlight breakthrough therapies

Express Pharma

Q. How will advanced methodologies like screening and sophisticated models benefit patients in India and around the world who suffer from neurological disorders? Response: Advanced methodologies like high-throughput screening and sophisticated models, such as human iPSC-derived organoids, fast-track the process of identification and validation of potential therapeutic compounds which is otherwise is slow and cumbersome.

article thumbnail

As GLP-1 sales surge, insulin users fear Novo Nordisk and Eli Lilly will move on without them

STAT

Around the world, patients suddenly can’t find enough of the insulins made by companies they have long relied on to do so. In the U.S., Novo Nordisk’s recent decision to discontinue a product has left patients with fewer options. At the same time, patients are encountering shortages of other products from Novo and Eli Lilly. For months, pharmacies have been running out of vials of certain insulins that patients use to fill the pumps they wear on their body.

Diabetes 363
article thumbnail

FDA launches innovation hub to spur rare disease R&D

pharmaphorum

FDA will create a rare disease hub to speed the development of new treatments and build connections between developers and the rare disease community

116
116
article thumbnail

In strengthening Spravato sales, a positive sign for psychedelic drugs

BioPharma Dive

Jefferies analyst Andrew Tsai views growing sales for J&J’s depression treatment as evidence that psychedelics like it can be commercially viable.

113
113
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Allergy Medications As Deprescribing Targets

Med Ed 101

Allergic rhinitis is a very common condition. I’ve encountered numerous patients throughout my career who take more than one medication to help keep their symptoms at bay. When reviewing polypharmacy cases, I do consider allergy medications as deprescribing targets because oftentimes allergy medications are added and the original success of the first agent is not […] The post Allergy Medications As Deprescribing Targets appeared first on Med Ed 101.

105
105
article thumbnail

STAT+: Top FDA officials weighing regulation of ultra-processed foods, internal documents show

STAT

WASHINGTON – Top Food and Drug Administration officials met multiple times earlier this year to discuss the regulation of ultra-processed foods, according to internal agency calendars obtained by STAT. Two FDA officials, Haider Warraich and Robin McKinnon, met multiple times in February to discuss regulating these edible industrial creations, such as sodas, prepackaged cookies, and most breakfast cereals.

article thumbnail

Susvimo Demonstrates Sustained Efficacy Over Two Years in Patients with Diabetic Macular Edema and Diabetic Retinopathy

Pharmaceutical Commerce

FDA to review one-year results for Susvimo showing non-inferior visual acuity gains in diabetic macular edema and in the Diabetic Retinopathy Severity Scale for Diabetic Retinopathy.

Diabetes 104
article thumbnail

Over-the-Counter Choices Pharmacist Role and Resources

FADIC

Top Most Common Over-the-Counter Pharmacist Resources What are OTC drugs? Over-the-counter (OTC) drugs refer to non-prescription medications that are readily available to consumers without the need for a doctor’s prescription. These drugs are typically used to treat common, self-diagnosable health issues, such as headaches, allergies, cold symptoms, and minor aches and pains.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

At Long Last, FDA Unveils Plan for Rare Disease Innovation Hub

FDA Law Blog: Biosimilars

By Sarah Wicks & James E. Valentine & Frank J. Sasinowski — On July 17, 2024, FDA announced the establishment of a Rare Disease Innovation Hub (the “Hub”) to enhance and improve outcomes for patients with rare diseases and conditions by focusing on rare disease drug and biological product development across the Agency’s Center for Drug Evaluation and Research (“CDER”) and Center for Biologics Evaluation and Research (“CBER”).

article thumbnail

Bird flu snapshot: As the number of infected dairy herds mount, so too does pessimism about driving H5N1 out of cows

STAT

Bird flu snapshot: This is the latest installment in a series of regular updates on the H5N1 flu outbreak in dairy cows that STAT is publishing on Monday mornings. To read future updates, you can also subscribe to STAT’s Morning Rounds newsletter. There are more human cases of H5N1 bird flu infection, and another state has joined the list of those with infected dairy cow herds.

363
363
article thumbnail

PDA accuses regulator of inaction and incompetence on training standards

The Pharmacist

A major pharmacists’ union has suggested that the pharmacy regulator has failed to take action on addressing potential racial bias and disparities in educational attainment. And it raised concerns about pharmacy technician training. In particular, it highlighted one provider that had 'softened' its science entry requirement. The Pharmacists’ Defence Association (PDA) was responding to the […] The post PDA accuses regulator of inaction and incompetence on training standards appeared first o

article thumbnail

Topiramate-Induced Cognitive Impairment

Med Ed 101

In this case scenario, I outline a situation of topiramate-induced cognitive impairment. Topiramate is an anticonvulsant medication that may be used for headache prophylaxis and is known to cause cognitive slowing, manifesting as difficulties in concentration, memory, and speech. JD is a 55-year-old male who presents to the clinic for a routine follow-up.

102
102
article thumbnail

Chimeric antigen receptor T-cells: Emerging uses and future directions

pharmaphorum

Explore the emerging uses and future directions of chimeric antigen receptor T-cell therapy targeting mRNA, anti-EGFRvIII, and anti-NY-ESO-1 antigens in cancer treatments.

110
110